Vir Biotechnology Inc (VIR)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,150,380 | 1,590,240 | 2,077,960 | 1,431,850 | 716,852 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,150,380K
= 0.00
The debt-to-equity ratio of Vir Biotechnology Inc has been consistently reported as 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt financing to support its operations and growth during this period. A debt-to-equity ratio of 0.00 suggests that the company has either zero or very minimal debt compared to its equity, which could signal financial stability and a lower risk of default. However, it is essential to consider other financial metrics and factors to gain a comprehensive understanding of Vir Biotechnology Inc's overall financial health and performance.
Peer comparison
Dec 31, 2024